When can an off-label drug be the appropriate comparator therapy?
This question was discussed at the recent G-BA meeting on 2 September 2021. Previously, the G-BA had decided on the following procedural
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
This question was discussed at the recent G-BA meeting on 2 September 2021. Previously, the G-BA had decided on the following procedural